search
Back to results

Evaluation of Safety and Efficacy of ReHub in Patients Who Underwent Primary Total Knee Arthroplasty (REHAPT)

Primary Purpose

Knee Osteoarthritis

Status
Completed
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
Rapid Recovery Rehabilitation Programme
ReHub
Sponsored by
Bio-Sensing Solutions S.L. (DyCare)
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Knee Osteoarthritis

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Candidates to primary TKA
  • Age from 18 to 75 years old
  • Ability to understand and accept the clinical study procedure and to sign an informed consent form
  • Good predisposition to the use of technology or cohabitation with someone that can give them technological support
  • Availability to attend the Hospital for control visits
  • Patient resides in the area of influence of Hospital Clínic de Barcelona

Exclusion Criteria:

  • Reluctance or inability to use technology
  • Any type of disability that could alter the homogeneity of the study
  • Sensory and/or cognitive impairment
  • Concomitant medical conditions that may influence the rehabilitation process
  • Any local or systemic complications after TKA surgery (e.g. surgical wound infection, suspicious of deep vein thrombosis)

Sites / Locations

  • Hospital Clinic of Barcelona

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Conventional Rehabilitation Group

ReHub Group

Arm Description

Participants follow the usual fast-track protocol used at Hospital Clínic de Barcelona for Total Knee Arthroplasty and perform a daily 5-exercise plan autonomously.

Participants follow the usual fast-track protocol used at Hospital Clínic de Barcelona for Total Knee Arthroplasty but use the telerehabilitation platform ReHub to do the exercises in their rehabilitation plan at home and to have their progress monitored.

Outcomes

Primary Outcome Measures

Change in Active Knee Range of Motion (º)
Range of motion of the replaced knee without the aid of the outcomes assessor will be measured with a conventional goniometer.

Secondary Outcome Measures

Change in the Timed Up-and-Go test score (s)
The TUG test outcome is the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down.
Change in Self-Reported Pain Level: Visual Analogue Scale
The pain level will be reported by the participant with a Visual Analogue Scale from 0 to 10, with 0 being the absence of pain and 10 being the worst pain imaginable.
Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score
Scores for the WOMAC questionnaire range from 0 to 96, with 0 being the best state and 96 the worst state.
Change in EuroQol-5D-5L (EQ-5D-5L) score
Scores for the EQ-5D-5L questionnaire are 5-digit numbers, each one representing a different aspect of quality of life. Digits can range from 1 to 5. 11111 is considered the ideal state and 55555 the worst state. 9 is used for absent or non-valid answers. The questionnaire also includes a Visual Analogue Scale for indicating perceived self's health state in a scale from 0 (worst state) to 100 (best state).
Change in Quadriceps Strength (kg)
Strength of the quadriceps in the intervened leg will be measured with a dynamometer.
Change in Hamstring Strength (kg)
Strength of the hamstring muscles in the intervened leg will be measured with a dynamometer.
Satisfaction with ReHub: System Usability Scale
Measured with the score from the System Usability Scale questionnaire, which can range from 0 (worst result) to 100 (best result). Only for participants in the experimental arm.
Change in Passive Knee Range of Motion (º)
Range of motion of the replaced knee with the aid of the outcomes assessor will be measured with a conventional goniometer.

Full Information

First Posted
November 4, 2019
Last Updated
June 7, 2021
Sponsor
Bio-Sensing Solutions S.L. (DyCare)
Collaborators
Hospital Clinic of Barcelona, EASME
search

1. Study Identification

Unique Protocol Identification Number
NCT04155957
Brief Title
Evaluation of Safety and Efficacy of ReHub in Patients Who Underwent Primary Total Knee Arthroplasty
Acronym
REHAPT
Official Title
Evaluation of Safety and Efficacy of ReHub in Patients Who Underwent Primary Total Knee Arthroplasty
Study Type
Interventional

2. Study Status

Record Verification Date
June 2021
Overall Recruitment Status
Completed
Study Start Date
November 25, 2019 (Actual)
Primary Completion Date
December 3, 2020 (Actual)
Study Completion Date
December 3, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Bio-Sensing Solutions S.L. (DyCare)
Collaborators
Hospital Clinic of Barcelona, EASME

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This is a randomized, non-blinded, parallel assignment, clinical trial for the evaluation of safety and efficacy of ReHub, a telerehabilitation system made up of a cloud platform and an exercise kit with smart sensors, for performing rehabilitation exercises after a primary Total Knee Arthroplasty. Primary TKA patients are allocated randomly to the control arm or the experimental arm with a 1:1 ratio. Both arms follow the usual rapid recovery protocol for TKA surgeries at Hospital Clínic de Barcelona, which includes discharge after 2-3 days from the surgery, the prescription of a daily plan of 5 exercises for autonomous rehabilitation and domiciliary visits by a physiotherapist starting approximately 2 weeks after the surgery. The experimental arm participants use ReHub to do their exercises instead of working independently and physiotherapists monitor their performance and adherence remotely. Outcomes assessment is performed at hospital discharge (baseline), at stitch removal (2 weeks after baseline) and 2 weeks after stitch removal (4 weeks after baseline).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Knee Osteoarthritis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
52 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Conventional Rehabilitation Group
Arm Type
Active Comparator
Arm Description
Participants follow the usual fast-track protocol used at Hospital Clínic de Barcelona for Total Knee Arthroplasty and perform a daily 5-exercise plan autonomously.
Arm Title
ReHub Group
Arm Type
Experimental
Arm Description
Participants follow the usual fast-track protocol used at Hospital Clínic de Barcelona for Total Knee Arthroplasty but use the telerehabilitation platform ReHub to do the exercises in their rehabilitation plan at home and to have their progress monitored.
Intervention Type
Other
Intervention Name(s)
Rapid Recovery Rehabilitation Programme
Intervention Description
Usual intervention at Hospital Clínic de Barcelona for post-operative rehabilitation of TKA patients. Participants, already at home after hospital discharge, must perform 5 different exercises 4 times a day (twice in the morning, twice in the afternoon). Participants are also encouraged to walk and stretch their legs. Domiciliary visits by a physiotherapist start at approximately 2 weeks after the surgery to help participants do the exercises.
Intervention Type
Device
Intervention Name(s)
ReHub
Intervention Description
Participants use a telerehabilitation platform, ReHub, as a guide to perform the TKA rehabilitation exercises of the Rapid Recovery Rehabilitation Programme intervention. The exercise plan in ReHub is carried out by a site physiotherapist on the first day after discharge by using ReHub to acquire the participant's movement pattern with a wearable inertial sensor that transmits data to the platform. The wearable inertial sensor participants must wear tracks movement while they do the TKA rehabilitation exercises. Movement is analysed and feedback is given in real time. At the end of each exercise, participants can select if they have felt pain in a scale from 1 to 10. A physiotherapist monitors the participants' progress remotely.
Primary Outcome Measure Information:
Title
Change in Active Knee Range of Motion (º)
Description
Range of motion of the replaced knee without the aid of the outcomes assessor will be measured with a conventional goniometer.
Time Frame
Baseline, 2 weeks and 4 weeks after discharge
Secondary Outcome Measure Information:
Title
Change in the Timed Up-and-Go test score (s)
Description
The TUG test outcome is the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down.
Time Frame
Baseline, 2 weeks and 4 weeks after discharge
Title
Change in Self-Reported Pain Level: Visual Analogue Scale
Description
The pain level will be reported by the participant with a Visual Analogue Scale from 0 to 10, with 0 being the absence of pain and 10 being the worst pain imaginable.
Time Frame
Baseline, 2 weeks and 4 weeks after discharge
Title
Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score
Description
Scores for the WOMAC questionnaire range from 0 to 96, with 0 being the best state and 96 the worst state.
Time Frame
Baseline, 2 weeks and 4 weeks after discharge
Title
Change in EuroQol-5D-5L (EQ-5D-5L) score
Description
Scores for the EQ-5D-5L questionnaire are 5-digit numbers, each one representing a different aspect of quality of life. Digits can range from 1 to 5. 11111 is considered the ideal state and 55555 the worst state. 9 is used for absent or non-valid answers. The questionnaire also includes a Visual Analogue Scale for indicating perceived self's health state in a scale from 0 (worst state) to 100 (best state).
Time Frame
Baseline, 2 weeks and 4 weeks after discharge
Title
Change in Quadriceps Strength (kg)
Description
Strength of the quadriceps in the intervened leg will be measured with a dynamometer.
Time Frame
Baseline, 2 weeks and 4 weeks after discharge
Title
Change in Hamstring Strength (kg)
Description
Strength of the hamstring muscles in the intervened leg will be measured with a dynamometer.
Time Frame
Baseline, 2 weeks and 4 weeks after discharge
Title
Satisfaction with ReHub: System Usability Scale
Description
Measured with the score from the System Usability Scale questionnaire, which can range from 0 (worst result) to 100 (best result). Only for participants in the experimental arm.
Time Frame
4 weeks after discharge
Title
Change in Passive Knee Range of Motion (º)
Description
Range of motion of the replaced knee with the aid of the outcomes assessor will be measured with a conventional goniometer.
Time Frame
Baseline, 2 weeks and 4 weeks after discharge

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Candidates to primary TKA Age from 18 to 75 years old Ability to understand and accept the clinical study procedure and to sign an informed consent form Good predisposition to the use of technology or cohabitation with someone that can give them technological support Availability to attend the Hospital for control visits Patient resides in the area of influence of Hospital Clínic de Barcelona Exclusion Criteria: Reluctance or inability to use technology Any type of disability that could alter the homogeneity of the study Sensory and/or cognitive impairment Concomitant medical conditions that may influence the rehabilitation process Any local or systemic complications after TKA surgery (e.g. surgical wound infection, suspicious of deep vein thrombosis)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Salvi Prat Fabregat
Organizational Affiliation
Hospital Clinic of Barcelona
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Clinic of Barcelona
City
Barcelona
ZIP/Postal Code
08036
Country
Spain

12. IPD Sharing Statement

Citations:
PubMed Identifier
34013143
Citation
Nuevo M, Mahdavi H, Rodriguez D, Faura T, Fabrellas N, Balocco S, Conti M, Castagna A, Prat S. Evaluation of Safety and Efficacy of ReHub in Patients Who Underwent Primary Total Knee Arthroplasty: Study Protocol for a Randomized Controlled Trial. Int J Surg Protoc. 2021 Apr 19;25(1):34-41. doi: 10.29337/ijsp.138.
Results Reference
derived

Learn more about this trial

Evaluation of Safety and Efficacy of ReHub in Patients Who Underwent Primary Total Knee Arthroplasty

We'll reach out to this number within 24 hrs